Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by F.M. Mtunzi
Total Records ( 1 ) for F.M. Mtunzi
  E. Muleya , A.S. Ahmed , A.M. Sipamla and F.M. Mtunzi
  Ledebouria revoluta, Berkheya setifera and Carissa bispinosa are some of the medicinal plants used in South African traditional medicine. An investigation to evaluate antimicrobial, anti-inflammatory and free radical scavenging activities of the root crude extracts and fractions from the three plants was carried out. Reduction by 2, 2-azinobis (3-ethylbenzothiazoline)-6-sulfonic acid (ABTS.+) and 2, 2-di (4-tert-octylphenyl)-1-picrylhydrazyl (DPPH.) radicals were used to assess antioxidant capacities by change in absorbance in a UV-VIS spectrophotometer. Anti-inflammatory activity of the plant extracts against 15-soybean derived lipoxygenase (15-LOX) enzyme was evaluated as increase in absorbance at 234 nm after addition of soya bean derived 15-LOX, using linoleic acid (134 µM) as substrate. Anti-microbial activities were determined by assessing the plant samples’Minimum Inhibitory Concentrations (MICs) by a micro dilution method. Carissa bispinosa and Berkheya setifera have shown good to moderate antimicrobial activity. Ledebouria revoluta displayed good activities (20 µg/mL) for both acetone and methanol fractions against E. coli and good-moderate activity (160-320 µg/mL) against the rest of the bacterial strains used. Anti-fungal activity for Ledebouria revoluta methanol fraction (20 µg/mL) is high against Candida albicans. Percentage inhibition of 15-soybean lipoxygenase enzyme by the crude extracts at concentration of 25 µg/mL was for Berkheya setifera, 80%, Carissa bispinosa, 65% and Ledebouria revoluta, 40%.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility